CMIP is oncogenic in human gastric cancer cells

Jianlin Zhang1, Jin Huang2, Xingyu Wang1

  • 1Department of Emergency Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, P.R. China.

Molecular Medicine Reports
|September 26, 2017
PubMed

Insights

c-Maf inducing protein (CMIP) drives gastric cancer growth and spread. Lowering CMIP levels inhibited cancer cell proliferation and migration, suggesting CMIP as a potential therapeutic target for gastric cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Gastric cancer is a leading cause of cancer mortality worldwide.
  • Recurrence, metastasis, and drug resistance impede survival in advanced gastric cancer.
  • Understanding molecular mechanisms is crucial for improving gastric cancer therapeutics.

Purpose of the Study:

  • To investigate the role of c-Maf inducing protein (CMIP) in human gastric cancer.
  • To explore the relationship between CMIP expression and clinical parameters, survival, and cellular behavior.
  • To elucidate the molecular pathways involving CMIP in gastric cancer.

Main Methods:

  • Immunohistochemistry and western blot analysis to assess CMIP protein levels.
  • In vitro assays (cell counting, CCK-8, colony formation, wound healing, Transwell) to evaluate CMIP's effect on cell proliferation and migration.
  • RNA interference (RNAi) for CMIP depletion.
  • Luciferase reporter assay and RT-qPCR to analyze upstream and downstream gene regulation.

Main Results:

  • CMIP protein expression was significantly elevated in gastric cancer tissues compared to normal tissues.
  • Higher CMIP expression correlated with poorer clinical parameters, relapse-free survival, and overall survival.
  • CMIP depletion reduced gastric cancer cell proliferation and migration in vitro.
  • CMIP was identified as a direct target of miR-101-3p.
  • CMIP knockdown led to downregulation of MDM2 and MAPK mRNA expression.

Conclusions:

  • CMIP exhibits an oncogenic role in human gastric cancer.
  • CMIP, miR-101-3p, MDM2, and MAPK are involved in a critical signaling pathway in gastric cancer.
  • CMIP represents a potential novel therapeutic target for gastric cancer management.

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.8K